Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Apr 03, 2025 Apr 03, 2025 SKB264 is currently in Phase II and Phase III clinical trials as a single agent/combination for multiple tumour types.
